Largest companies in Malaysia
The 16 companies domiciled in Malaysia that trade on a US exchange, ranked by market capitalisation. Domicile comes from each company's own SEC filing, so a company headquartered here but listed only on its home market does not appear.
Combined market cap
$235.364 M
0.00% of all US-listed value
Companies
16
Ranked #54 of 55 countries
Average
$14.710 M
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 1 | MeganMGN | $58.4M | $3.60 | -1.10% | Malaysia |
| 2 | Alps GroupALPS | $53.2M | $0.32 | -0.06% | Malaysia |
| 3 | Bradbury CapitalBBCI | $46.4M | $1.15 | -27.94% | Malaysia |
| 4 | CCHCCHH | $16.6M | $0.81 | -4.67% | Malaysia |
| 5 | Sagtec GlobalSAGT | $16.1M | $0.81 | +1.82% | Malaysia |
| 6 | TMD EnergyTMDE | $11.5M | $0.49 | -2.93% | Malaysia |
| 7 | CBL InternationalBANL | $7.25M | $2.90 | -0.34% | Malaysia |
| 8 | ARB IOT GroupARBB | $6.18M | $3.50 | +7.36% | Malaysia |
| 9 | Black TitanBTTC | $4.33M | $0.29 | -9.56% | Malaysia |
| 10 | AgrozAGRZ | $3.39M | $1.79 | -6.64% | Malaysia |
| 11 | VCI GlobalVCIG | $3.14M | $5.86 | +9.13% | Malaysia |
| 12 | WFWFF | $2.89M | $1.15 | -12.88% | Malaysia |
| 13 | BioNexus Gene LabBGLC | $2.51M | $0.86 | -10.78% | Malaysia |
| 14 | Agape ATPATPC | $1.34M | $1.34 | -10.07% | Malaysia |
| 15 | Linkers IndustriesLNKS | $1.05M | $0.59 | +1.72% | Malaysia |
| 16 | Founder GroupFGL | $1.03M | $1.24 | -11.79% | Malaysia |
All 16 companies. One row per company, with secondary share classes folded into their primary listing.
Other countries
🇺🇸 United States 4,017🇨🇦 Canada 244🇬🇧 United Kingdom 74🇹🇼 Taiwan 23🇳🇱 Netherlands 25🇯🇵 Japan 27🇰🇷 South Korea 13🇨🇭 Switzerland 26🇮🇪 Ireland 23🇨🇳 China 249🇧🇷 Brazil 28🇩🇪 Germany 14🇦🇺 Australia 30🇫🇷 France 16🇲🇽 Mexico 16🇮🇳 India 9🇪🇸 Spain 5🇱🇺 Luxembourg 16🇩🇰 Denmark 7🇮🇹 Italy 5🇮🇱 Israel 117🇧🇲 Bermuda 36🇧🇪 Belgium 7🇰🇾 Cayman Islands 29All countries →
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.